From September 9, 2021 to March 23, 2022, the company has repurchased 9,043,000 shares, representing 1.17% for HKD 18.47 million. With this, the company has completed the repurchase of 9,043,000 shares, representing 1.17% for HKD 18.47 million under the buyback announced on September 10, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 HKD | 0.00% | +0.84% | -12.41% |
1st Jan change | Capi. | |
---|---|---|
-12.41% | 114M | |
+16.31% | 42.32B | |
+16.32% | 21.29B | |
+19.33% | 15.29B | |
+18.71% | 14.36B | |
+52.78% | 12.81B | |
-0.05% | 6.79B | |
-12.24% | 6.58B | |
-8.87% | 5.73B | |
+11.64% | 5.51B |
- Stock Market
- Equities
- 1652 Stock
- News Fusen Pharmaceutical Company Limited
- Tranche Update on Fusen Pharmaceutical Company Limited's Equity Buyback Plan announced on September 10, 2021.